Article
BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment
3 Nov 2022
Abstract excerpt
Butyrophilin-3A (BTN3A) subfamily members are a group of immunoglobulins present on the surface of different cell types, including innate and cancer cells. Due to their high similarity with the B7 family members, different studies have been conducted and revealed the involvement of BTN3A molecules in modulating T cell activity within the tumor microenvironment (TME). However, a great part of this research focused...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
